Anthony Boral
Corporate Officer/Principal en BLUEPRINT MEDICINES CORPORATION .
Perfil
Anthony L. Boral es Vicepresidente Ejecutivo de Desarrollo Clínico en Blueprint Medicines Corp. En su anterior carrera ocupó el cargo de Vicepresidente de Investigación Clínica en Oncología en Millennium Pharmaceuticals, Inc. y Director Ejecutivo de Investigación Clínica en Oncología en Novartis Institutes for Biomedical Research, Inc. Se doctoró en el Albert Einstein College of Medicine, Inc. y se licenció en la Wesleyan University.
Cargos activos de Anthony Boral
Empresas | Cargo | Inicio |
---|---|---|
BLUEPRINT MEDICINES CORPORATION | Corporate Officer/Principal | 11/01/2021 |
Antiguos cargos conocidos de Anthony Boral.
Empresas | Cargo | Fin |
---|---|---|
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/02/2015 |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01/10/2010 |
Formación de Anthony Boral.
Wesleyan University | Undergraduate Degree |
Albert Einstein College of Medicine, Inc. | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
BLUEPRINT MEDICINES CORPORATION | Health Technology |
Empresas privadas | 2 |
---|---|
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Novartis Institutes for Biomedical Research, Inc.
Novartis Institutes for Biomedical Research, Inc. Miscellaneous Commercial ServicesCommercial Services Novartis Institutes for Biomedical Research, Inc. conducts biomedical researches. It focuses in the areas of oncology, ophthalmology, diabetes, musculoskeletal disorders, neuroscience, and cardiovascular conditions, other focus areas include discovery chemistry, biologics, pathway biology, and translational medicine. The company was founded on September 10, 2002 and is headquartered in Cambridge, MA. | Commercial Services |
- Bolsa de valores
- Insiders
- Anthony Boral